Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLXT

Calyxt (CLXT) Stock Price, News & Analysis

Calyxt logo

About Calyxt Stock (NASDAQ:CLXT)

Advanced Chart

Key Stats

Today's Range
$6.01
$7.77
50-Day Range
$6.30
$31.50
52-Week Range
$1.25
$7.77
Volume
254,056 shs
Average Volume
139,308 shs
Market Capitalization
$31.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.

Receive CLXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calyxt and its competitors with MarketBeat's FREE daily newsletter.

CLXT Stock News Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Calyxt Completes One-for-Ten Reverse Stock Split
See More Headlines

CLXT Stock Analysis - Frequently Asked Questions

Calyxt, Inc. (NASDAQ:CLXT) posted its earnings results on Monday, May, 1st. The company reported ($5.45) EPS for the quarter, missing analysts' consensus estimates of ($3.00) by $2.45. The company earned $0.04 million during the quarter. Calyxt had a negative net margin of 9,979.64% and a negative trailing twelve-month return on equity of 259.69%.

Calyxt shares reverse split on Thursday, June 1st 2023. The 1-5 reverse split was announced on Thursday, June 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Calyxt (CLXT) raised $101 million in an initial public offering on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Calyxt investors own include Cellectis (CLLS), Intel (INTC), Plug Power (PLUG), First Solar (FSLR), Intellia Therapeutics (NTLA), NVIDIA (NVDA) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
5/01/2023
Today
5/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CLXT
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-16,890,000.00
Net Margins
-9,979.64%
Pretax Margin
-9,979.64%

Debt

Sales & Book Value

Annual Sales
$160,000.00
Price / Cash Flow
N/A
Book Value
$0.54 per share
Price / Book
11.67

Miscellaneous

Free Float
4,865,000
Market Cap
$31.31 million
Optionable
Not Optionable
Beta
1.98

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:CLXT) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners